[Federal Register Volume 60, Number 169 (Thursday, August 31, 1995)]
[Notices]
[Pages 45487-45488]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-21604]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of AIDS Research; Amended Notice of Meeting
Notice is hereby given to amend the notice of the meeting of the
NIH AIDS Research Program Evaluation Working Group that was published
in the Federal Register on August 24, 1995 (60 FR 44039) to provide
additional background information about the meeting and to establish
specific guidelines for presentations by public participants. The open
portion of the meeting will be held on September 13, 1995 at the Omni
Shoreham Hotel, 2500 Calvert Street NW., Washington, DC, from 10:30
a.m. until 5 p.m.
The NIH Revitalization Act of 1993 authorizes the Office of AIDS
Research
[[Page 45488]]
(OAR) to evaluate the AIDS research activities of the NIH. The NIH AIDS
Research Program Evaluation Working Group was established by the OAR to
carry out this major evaluation initiative, reviewing and assessing
each of the components of the NIH AIDS research endeavor to determine
whether those components are appropriately designed and coordinated to
answer the critical scientific questions to lead to better treatments,
prevention, and a cure for AIDS. Six Area Review Panels were also
established to address the following research areas: Natural History
and Epidemiology; Etiology and Pathogenesis; Clinical Trials; Drug
Development; Vaccine Research; and Behavioral and Social Sciences
Research.
The purpose of the meeting is to review the status of efforts of
each of the six Area Review Panels and to seek input from individuals
and organizations interested in the evaluation of AIDS research.
During the session from 10:30 until 12:30 p.m., each of the Chairs
of the Area Review Panels will present reports on the efforts of the
Panels. The afternoon session from 1:30 until 5:00 will be devoted to
presentations from the public. These sessions are open to the public;
however, attendance may be limited by seat availability.
Comments should be confined to statements related to the current
status of NIH AIDS Research and recommendations for consideration by
the panel in assessing and reviewing the major biomedical and
behavioral research components.
Only one representative of an organization may present oral
comments. Each speaker will be permitted 5 minutes for their
presentation. Interested individuals and representatives of
organizations must submit a letter of intent to present comments and
three (3) typewritten copies of the presentation, along with a brief
description of the organization represented, to the attention of: Dr.
Robert Eisinger, Office of AIDS Research, NIH, 31 Center Drive, MSC
2340, Building 31, Room 4B62, Bethesda, Maryland 20892-2340; telephone:
301-402-8655; FAX: 301-402-8638. Letters of intent and copies of
presentations must be received no later than 5:00 p.m. edt on September
8, 1995.
Individuals wishing to provide only written statements must send
three (3) typewritten copies of their comments, including a brief
description of their organization, to the above address no later than 5
p.m. edt on September 8, 1995. Statements submitted after that date
will be accepted, but may not be available to the Evaluation Working
Group prior to the meeting.
Dated: August 25, 1995.
Margery G. Grubb,
Senior Committee Management Specialist.
[FR Doc. 95-21604 Filed 8-30-95; 8:45 am]
BILLING CODE 4140-01-M
